Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02658890
Title An Investigational Immuno-therapy Study of BMS-986205 Given in Combination With Nivolumab and in Combination With Both Nivolumab and Ipilimumab in Cancers That Are Advanced or Have Spread
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

BMS-986205 + Ipilimumab + Nivolumab

BMS-986205 + Nivolumab

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN

Facility Status City State Zip Country Details
University of Arizona Cancer Center Tucson Arizona 85724-5024 United States Details
UCSD Moores Cancer Center La Jolla California 92093-0698 United States Details
H. Lee Moffitt Cancer Center Tampa Florida 33612-9497 United States Details
Emory Winship Cancer Institute Atlanta Georgia 30322 United States Details
Northside Hospital, Inc Atlanta Georgia 30342 United States Details
University Of Chicago Chicago Illinois 60637 United States Details
Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Lutherville Maryland 21093 United States Details
Barbara Ann Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Washington University Saint Louis Missouri 63110 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
New York University New York New York 10016 United States Details
Cleveland Clinic Cleveland Ohio 44195 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111-2412 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
The Kinghorn Cancer Centre Darlinghurst New South Wales 2010 Australia Details
Melanoma Institute Australia North Sydney New South Wales 2146 Australia Details
Local Institution Westmead New South Wales 2145 Australia Details
Princess Alexandra Hospital Brisbane Queensland 4102 Australia Details
Local Institution Clayton Victoria 3168 Australia Details
Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia Details
Linear Clinical Research Ltd Nedlands Western Australia 6009 Australia Details
Cross Cancer Institute Edmonton Alberta T6G 1Z2 Canada Details
Local Institution Vancouver British Columbia V5Z 4E6 Canada Details
Local Institution Toronto Ontario M5G 1Z5 Canada Details
Local Institution Greenfield Park Quebec J4V 2H1 Canada Details
Jewish General Hospital Montreal Quebec H3T 1E2 Canada Details
Local Institution Helsinki 00180 Finland Details
Hopital Claude Huriez Lille CEDEX 59037 France Details
Local Institution Lyon Cedex 08 69373 France Details
Local Institution Marseille Cedex 5 13385 France Details
Hotel Dieu - Chu De Nantes Nantes Cedex 01 44093 France Details
Local Institution Paris 75005 France Details
Local Institution Toulouse 31100 France Details
Institut Gustave Roussy Villejuif 94800 France Details
Local Institution Essen 45147 Germany Details
Local Institution Heilbronn 74078 Germany Details
Ospedale San Raffaele Milano 20132 Italy Details
IRCCS Istituto Nazionale Tumori Milano Milano 20133 Italy Details
Istituto Europeo Di Oncologia Milano 20141 Italy Details
Istituto Clinico Humanitas Rozzano MI 20089 Italy Details
Local Institution Oslo 0424 Norway Details
Oddzial Badan Wczesnych Faz Warszawa Mazowieckie 02-781 Poland Details
Local Institution Barcelona 08035 Spain Details
Local Institution Madrid 28040 Spain Details
Local Institution Madrid 28050 Spain Details
Local Institution Solna 171 64 Sweden Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field